{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:39:57Z","timestamp":1792175997450,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Project and a Lab Project of Chongqing Three Gorges Medical College of China","award":["SYS20210021"],"award-info":[{"award-number":["SYS20210021"]}]},{"name":"Chongqing Education Commission Science and Technology Research Program Project","award":["KJQN202302715"],"award-info":[{"award-number":["KJQN202302715"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10809-1","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:45:41Z","timestamp":1772887541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The association between systemic inflammation markers and breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"SiQi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CuiTing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaFeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"10809_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"10809_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"10809_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold, M. et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66, 15\u201323 (2022).","journal-title":"Breast"},{"key":"10809_CR4","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","volume":"380","author":"The benefits","year":"2012","unstructured":"The benefits. And harms of breast cancer screening: an independent review. Lancet 380, 1778\u20131786 (2012).","journal-title":"Lancet"},{"key":"10809_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436\u2013444 (2008).","journal-title":"Nature"},{"key":"10809_CR6","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos, C. I., Charles, K. A., McMillan, D. C. & Clarke, S. J. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 15, e493\u2013503 (2014).","journal-title":"Lancet Oncol."},{"key":"10809_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fimmu.2019.00071","volume":"10","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Scoring system for Tumor-Infiltrating lymphocytes and its prognostic value for gastric Cancer. Front. Immunol. 10, 71 (2019).","journal-title":"Front. Immunol."},{"key":"10809_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/annonc\/mdv560","volume":"27","author":"T Donnem","year":"2016","unstructured":"Donnem, T. et al. Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer. Ann. Oncol. 27, 225\u2013232 (2016).","journal-title":"Ann. Oncol."},{"key":"10809_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado, R. et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014. Ann. Oncol. 26, 259\u2013271 (2015).","journal-title":"Ann. Oncol."},{"key":"10809_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fonc.2018.00078","volume":"8","author":"JL Sylman","year":"2018","unstructured":"Sylman, J. L. et al. The predictive value of Inflammation-Related peripheral blood measurements in Cancer staging and prognosis. Front. Oncol. 8, 78 (2018).","journal-title":"Front. Oncol."},{"key":"10809_CR11","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu, B. et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin. Cancer Res. 20, 6212\u20136222 (2014).","journal-title":"Clin. Cancer Res."},{"key":"10809_CR12","doi-asserted-by":"publisher","first-page":"922595","DOI":"10.3389\/fsurg.2022.922595","volume":"9","author":"X Li","year":"2022","unstructured":"Li, X., Zhang, S., Lu, J., Li, C. & Li, N. The prognostic value of systemic immune-inflammation index in surgical esophageal cancer patients: an updated meta-analysis. Front. Surg. 9, 922595 (2022).","journal-title":"Front. Surg."},{"key":"10809_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10654-021-00752-6","volume":"36","author":"TH N\u00f8st","year":"2021","unstructured":"N\u00f8st, T. H. et al. Systemic inflammation markers and cancer incidence in the UK biobank. Eur. J. Epidemiol. 36, 841\u2013848 (2021).","journal-title":"Eur. J. Epidemiol."},{"key":"10809_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/ijc.32303","volume":"146","author":"J Fest","year":"2020","unstructured":"Fest, J. et al. The systemic immune-inflammation index is associated with an increased risk of incident cancer-A population-based cohort study. Int. J. Cancer. 146, 692\u2013698 (2020).","journal-title":"Int. J. Cancer"},{"key":"10809_CR15","first-page":"1","volume":"1","author":"G Zipf","year":"2013","unstructured":"Zipf, G. et al. National health and nutrition examination survey: plan and operations, 1999\u20132010. Vital Health Stat. 1, 1\u201337 (2013).","journal-title":"Vital Health Stat."},{"key":"10809_CR16","first-page":"249","volume":"26","author":"MM Bala","year":"2022","unstructured":"Bala, M. M. & Bala, K. A. Bone mineral density and complete blood count ratios in children and adolescents with obesity. Eur. Rev. Med. Pharmacol. Sci. 26, 249\u2013256 (2022).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10809_CR17","doi-asserted-by":"publisher","first-page":"2179856","DOI":"10.1080\/0886022X.2023.2179856","volume":"45","author":"D Zhou","year":"2023","unstructured":"Zhou, D. et al. Calculated inflammatory markers derived from complete blood count results, along with routine laboratory and clinical data, predict treatment failure of acute peritonitis in chronic peritoneal dialysis patients. Ren. Fail. 45, 2179856 (2023).","journal-title":"Ren. Fail."},{"key":"10809_CR18","doi-asserted-by":"publisher","first-page":"1115031","DOI":"10.3389\/fimmu.2023.1115031","volume":"14","author":"RH Wang","year":"2023","unstructured":"Wang, R. H. et al. The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage. Front. Immunol. 14, 1115031 (2023).","journal-title":"Front. Immunol."},{"key":"10809_CR19","doi-asserted-by":"publisher","first-page":"1163900","DOI":"10.3389\/fcvm.2023.1163900","volume":"10","author":"J Xiu","year":"2023","unstructured":"Xiu, J. et al. The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension. Front. Cardiovasc. Med. 10, 1163900 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"10809_CR20","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2337\/dc21-2371","volume":"45","author":"Z Qiu","year":"2022","unstructured":"Qiu, Z. et al. Associations of serum carotenoids with risk of cardiovascular mortality among individuals with type 2 diabetes: results from NHANES. Diabetes Care. 45, 1453\u20131461 (2022).","journal-title":"Diabetes Care"},{"key":"10809_CR21","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1186\/s12885-020-07700-9","volume":"20","author":"JY Kim","year":"2020","unstructured":"Kim, J. Y. et al. Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis. BMC Cancer. 20, 1206 (2020).","journal-title":"BMC Cancer"},{"key":"10809_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13058-022-01563-7","volume":"24","author":"H Onagi","year":"2022","unstructured":"Onagi, H. et al. High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs. Breast Cancer Res. 24, 67 (2022).","journal-title":"Breast Cancer Res."},{"key":"10809_CR23","doi-asserted-by":"publisher","first-page":"e074874","DOI":"10.1136\/bmjopen-2023-074874","volume":"13","author":"X Qi","year":"2023","unstructured":"Qi, X. et al. Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis. BMJ Open. 13, e074874 (2023).","journal-title":"BMJ Open."},{"key":"10809_CR24","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1002\/cam4.2281","volume":"8","author":"W Guo","year":"2019","unstructured":"Guo, W. et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: an updated meta-analysis of 17079 individuals. Cancer Med. 8, 4135\u20134148 (2019).","journal-title":"Cancer Med."},{"key":"10809_CR25","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.2147\/IJGM.S411592","volume":"16","author":"L Tong","year":"2023","unstructured":"Tong, L. et al. High levels of SII and PIV are the risk factors of axillary lymph node metastases in breast cancer: A retrospective study. Int. J. Gen. Med. 16, 2211\u20132218 (2023).","journal-title":"Int. J. Gen. Med."},{"key":"10809_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12885-024-11931-5","volume":"24","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Healthy lifestyles, systemic inflammation and breast cancer risk: a mediation analysis. BMC Cancer. 24, 208 (2024).","journal-title":"BMC Cancer"},{"key":"10809_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10549-020-05925-7","volume":"185","author":"S Tiainen","year":"2021","unstructured":"Tiainen, S., Rilla, K., H\u00e4m\u00e4l\u00e4inen, K., Oikari, S. & Auvinen, P. The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2\u2009+\u2009subtype. Breast Cancer Res. Treat. 185, 63\u201372 (2021).","journal-title":"Breast Cancer Res. Treat."},{"key":"10809_CR28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3233\/CBM-201682","volume":"28","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. Prognostic value of the systemic inflammation response index (SIRI) before and after surgery in operable breast cancer patients. Cancer Biomark. 28, 537\u2013547 (2020).","journal-title":"Cancer Biomark."},{"key":"10809_CR29","doi-asserted-by":"publisher","first-page":"665534","DOI":"10.3389\/fonc.2021.665534","volume":"11","author":"A Braun","year":"2021","unstructured":"Braun, A., Anders, H. J., Gudermann, T. & Mammadova-Bach, E. Platelet-Cancer interplay: molecular mechanisms and new therapeutic avenues. Front. Oncol. 11, 665534 (2021).","journal-title":"Front. Oncol."},{"key":"10809_CR30","doi-asserted-by":"crossref","unstructured":"Stoiber, D. & Assinger, A. Platelet-leukocyte interplay in cancer development and progression. Cells 9 (2020).","DOI":"10.3390\/cells9040855"},{"key":"10809_CR31","doi-asserted-by":"crossref","unstructured":"Wang, S., Li, Z. & Xu, R. Human cancer and platelet interaction, a potential therapeutic target. Int J. Mol. Sci. 19 (2018).","DOI":"10.3390\/ijms19041246"},{"issue":"Suppl 1","key":"10809_CR32","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.thromres.2017.12.016","volume":"164","author":"P Gresele","year":"2018","unstructured":"Gresele, P., Malvestiti, M. & Momi, S. Anti-platelet treatments in cancer: basic and clinical research. Thromb. Res. 164 (Suppl 1), S106\u2013S111 (2018).","journal-title":"Thromb. Res."},{"key":"10809_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-019-0721-x","volume":"12","author":"A Li","year":"2019","unstructured":"Li, A. et al. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy. J. Hematol. Oncol. 12, 35 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"10809_CR34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10555-021-09968-0","volume":"40","author":"MA Nelson","year":"2021","unstructured":"Nelson, M. A., Ngamcherdtrakul, W., Luoh, S. W. & Yantasee, W. Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer. Cancer Metastasis Rev. 40, 519\u2013536 (2021).","journal-title":"Cancer Metastasis Rev."},{"key":"10809_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s43440-022-00426-4","volume":"75","author":"B Starek-\u015awiechowicz","year":"2023","unstructured":"Starek-\u015awiechowicz, B., Budziszewska, B. & Starek, A. Alcohol and breast cancer. Pharmacol. Rep. 75, 69\u201384 (2023).","journal-title":"Pharmacol. Rep."},{"key":"10809_CR36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5694\/mja16.01007","volume":"205","author":"IN Olver","year":"2016","unstructured":"Olver, I. N. Prevention of breast cancer. Med. J. Aust. 205, 475\u2013479 (2016).","journal-title":"Med. J. Aust"},{"key":"10809_CR37","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Bayona, R. et al. Binge drinking and risk of breast cancer: Results from the SUN (\u2018Seguimiento Universidad de Navarra\u2019) project. Nutrients 12 (2020).","DOI":"10.3390\/nu12030731"},{"key":"10809_CR38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"10809_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/1078-0432.CCR-08-0149","volume":"15","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal, B. B., Vijayalekshmi, R. V. & Sung, B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin. Cancer Res. 15, 425\u2013430 (2009).","journal-title":"Clin. Cancer Res."},{"key":"10809_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ccr.2009.12.008","volume":"17","author":"H Takahashi","year":"2010","unstructured":"Takahashi, H., Ogata, H., Nishigaki, R., Broide, D. H. & Karin, M. Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell. 17, 89\u201397 (2010).","journal-title":"Cancer Cell."},{"key":"10809_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"Park, E. J. et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197\u2013208 (2010).","journal-title":"Cell"},{"key":"10809_CR42","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/CMR.00011-10","volume":"23","author":"LE Wroblewski","year":"2010","unstructured":"Wroblewski, L. E., Peek, R. M. Jr. & Wilson, K. T. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin. Microbiol. Rev. 23, 713\u2013739 (2010).","journal-title":"Clin. Microbiol. Rev."},{"key":"10809_CR43","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2013.07.030","volume":"345","author":"SA Read","year":"2014","unstructured":"Read, S. A. & Douglas, M. W. Virus induced inflammation and cancer development. Cancer Lett. 345, 174\u2013181 (2014).","journal-title":"Cancer Lett."},{"key":"10809_CR44","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/1878-0261.12095","volume":"11","author":"M Suarez-Carmona","year":"2017","unstructured":"Suarez-Carmona, M., Lesage, J., Cataldo, D. & Gilles, C. EMT and inflammation: inseparable actors of cancer progression. Mol. Oncol. 11, 805\u2013823 (2017).","journal-title":"Mol. Oncol."},{"key":"10809_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10549-006-9328-3","volume":"102","author":"H Kn\u00fcpfer","year":"2007","unstructured":"Kn\u00fcpfer, H. & Preiss, R. Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res. Treat. 102, 129\u2013135 (2007).","journal-title":"Breast Cancer Res. Treat."},{"key":"10809_CR46","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/ijc.24172","volume":"124","author":"JL Barclay","year":"2009","unstructured":"Barclay, J. L., Anderson, S. T., Waters, M. J. & Curlewis, J. D. SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL. Int. J. Cancer. 124, 1756\u20131766 (2009).","journal-title":"Int. J. Cancer"},{"key":"10809_CR47","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1177\/1947601911407325","volume":"1","author":"MM Georgescu","year":"2010","unstructured":"Georgescu, M. M. PTEN tumor suppressor network in PI3K-Akt pathway control. Genes Cancer. 1, 1170\u20131177 (2010).","journal-title":"Genes Cancer"},{"key":"10809_CR48","doi-asserted-by":"publisher","first-page":"19480","DOI":"10.1002\/jcp.28742","volume":"234","author":"A Bahiraee","year":"2019","unstructured":"Bahiraee, A., Ebrahimi, R., Halabian, R., Aghabozorgi, A. S. & Amani, J. The role of inflammation and its related MicroRNAs in breast cancer: A narrative review. J. Cell. Physiol. 234, 19480\u201319493 (2019).","journal-title":"J. Cell. Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10809-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10809-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10809-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:03:40Z","timestamp":1774307020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10809-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10809"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10809-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9564"}}